Crossmark

First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1–5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major

Crossref DOI link: https://doi.org/10.1007/s12013-026-02003-5

Published Online: 2026-01-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Malik, Deepti

Thakur, Kiran

Kumar, Rakesh

Kumar, Bhupender

Singh, Jitender

Sharma, Sadhna
Funding

Funding for this research was provided by:

All-India Institute of Medical Sciences
License Information

Text and Data Mining valid from 2026-01-20

Version of Record valid from 2026-01-20
More Information

Article History

Accepted: 8 January 2026

First Online: 20 January 2026

Declarations

:

: The authors declare no competing interests.

: The study was approved by Institutional Ethics Committee. Written informed consents were obtained from the patients for the publication of the findings.

Document is current

Any future updates will be listed below